DCGO Earnings Date & History
DocGo Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:06 PM ET
DocGo Inc
Health Care
- Next earnings date
- Monday, November 9, 2026
- Reporting session
- After Close
- EPS estimate
- $-0.03
- Revenue estimate
- $77.8M
DCGO earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Monday, August 17, 2026 | Q2 2026 | $-0.06 | $0.16 | +353.2% | $73.4M |
| Monday, May 11, 2026 | Q1 2026 | $-0.10 | $-0.13 | -36.6% | $75.5M |
| Monday, March 16, 2026 | Q4 2025 | $-0.13 | $-1.37 | -920.1% | $74.9M |
| Monday, November 10, 2025 | Q3 2025 | $-0.12 | $-0.11 | +4.2% | $70.8M |
| Thursday, August 7, 2025 | Q2 2025 | $-0.10 | $-0.11 | -14.3% | $80.4M |
What the market is watching in DCGO's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next DCGO earnings date?
- DocGo Inc is scheduled to report on Monday, November 9, 2026 (After Close). Dates can change until the company confirms them.
- Does DCGO report before or after the market?
- The next report is scheduled after close.
- What EPS is expected for DCGO?
- Consensus EPS for the upcoming quarter is $-0.03, on revenue of $77.8M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
DCGO earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.